Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alpha IVF Group BhdXKLS:0303 53 Debt-to-Equity is 0.18 as of May. 2026, which is 60% below its 10-year median of 0.45. GuruFocus rates XKLS:0303 with a GF Score™ of 53/100. The stock has 2 warning signs investors should review. Among 560 Healthcare Providers & Services companies, Alpha IVF Group Bhd ranks better than 70.89% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Alpha IVF Group Bhd's Debt-to-Equity or its related term are showing as below:
XKLS:0303'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.09 Med: 0.45 Max: 1.9
Current: 0.18
During the past 7 years, the highest Debt-to-Equity Ratio of Alpha IVF Group Bhd was 1.90. The lowest was 0.09. And the median was 0.45.
XKLS:0303's Debt-to-Equity is ranked better than 70.89% of 560
companies
in the Healthcare Providers & Services industry
Industry Median: 0.42
vs XKLS:0303: 0.18
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Alpha IVF Group Bhd Debt-to-Equity Related Terms
Alpha IVF Group Bhd Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Alpha IVF Group Bhd's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0303 vs HCA, THC, DVA: Debt-to-Equity Comparison
For the Medical Care Facilities subindustry, Alpha IVF Group Bhd's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpha IVF Group Bhd Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alpha IVF Group Bhd's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Alpha IVF Group Bhd's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alpha IVF Group Bhd (XKLS:0303) has a Debt-to-Equity of 0.18 as of May. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Alpha IVF Group Bhd and its competitors. This is 60% below median its historical median of 0.45. Over the past decade, Alpha IVF Group Bhd's Debt-to-Equity has ranged from 0.09 to 1.90. According to the industry distribution chart, Alpha IVF Group Bhd ranks #163 out of 560 companies in the Healthcare Providers & Services industry, placing it in the top 29.1%.
Is Alpha IVF Group Bhd's Debt-to-Equity too high?
Alpha IVF Group Bhd's current Debt-to-Equity of 0.18 is 60% below median its 10-year median of 0.45. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 1.90. The Healthcare Providers & Services industry median Debt-to-Equity is 0.42. Alpha IVF Group Bhd's value of 0.18 is 57.1% below this industry median. Based on the distribution chart, Alpha IVF Group Bhd ranks #163 out of 560 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Alpha IVF Group Bhd has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Alpha IVF Group Bhd's Debt-to-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Alpha IVF Group Bhd ranks #163 out of 560 companies for Debt-to-Equity. This puts Alpha IVF Group Bhd in the upper half of its industry. The industry median Debt-to-Equity is 0.42. Alpha IVF Group Bhd's value of 0.18 is 57.1% below this benchmark. Historically, Alpha IVF Group Bhd's own Debt-to-Equity has ranged from 0.09 to 1.90 over the past decade. While the company's 10-year median is 0.45 vs. the industry median of 0.42, Alpha IVF Group Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.42, based on 560 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alpha IVF Group Bhd's current Debt-to-Equity of 0.18 is 57.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Alpha IVF Group Bhd and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpha IVF Group Bhd's current Debt-to-Equity is 0.18, which is 60% below median its own 10-year median of 0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha IVF Group Bhd stock overvalued right now?
Alpha IVF Group Bhd (XKLS:0303) has a current Debt-to-Equity of 0.18. The current Debt-to-Equity is 0.18, which is 60% below median its 10-year median of 0.45 and 57.1% below the Healthcare Providers & Services industry median of 0.42. Alpha IVF Group Bhd's overall GF Score™ is 53/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Alpha IVF Group Bhd (XKLS:0303), the current Debt-to-Equity is 0.18 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alpha IVF Group Bhd is a fertility care specialist focusing on assisted reproductive services in Malaysia, Singapore, Indonesia, and China, with the majority of its revenue coming from Malaysia. Assisted reproductive services is a general term that includes all types of fertility treatments and procedures to help people facing difficulties in getting pregnant. The company offers a range of assisted reproductive services such as IVF to assist patients with infertility conditions in achieving clinical pregnancy. It also provides other procedures including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), various diagnostic, testing, and screening procedures, as well as cryopreservation of eggs, sperm, and embryos.
53GF Score
Get the complete analysis for XKLS:0303
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0303 has been successfully added to your 
